Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Taro to Announce Second Quarter Results on October 28, 2020


Business Wire | Oct 21, 2020 06:44PM EDT

Taro to Announce Second Quarter Results on October 28, 2020

Oct. 21, 2020

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Oct. 21, 2020--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2020, on Wednesday, October 28, 2020.

The Company will conduct an earnings call at 8:00 am ET on Thursday, October 29, 2020, where senior management will discuss the Company's performance and answer questions from participants.

The release will be accessible on Taro's website at www.taro.com.

Earnings Call (8:00 am ET on Thursday, October 29, 2020)

To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.

Summary of events

Event Date and time Telephone number/ website

Earnings October 28, www.taro.comrelease 2020 (AMC)

Participant Toll-Free Dial-In Number: +1 (844) 421-0601 Participant International Dial-In Number: +1 October 29, (716) 247-5800Earnings 2020 ID: 3484939conference call 8:00 am ET

Via audio webcast, details of which will be made available on www.taro.com

+ 1 (855) 859-2056 or +1 (404) 537-3406 October 29, ID: 3484939Replay of 2020 toconference call November 5, 2020 Via audio webcast playback, details of which will be made available on www.taro.com

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company's website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201021006072/en/

CONTACT: Daphne Huang VP, CFO (914) 345-9001 Daphne.Huang@taro.com

CONTACT: William J. Coote AVP, Treasurer and Investor Relations (914) 345-9001 William.Coote@taro.com






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC